Drug Type Small molecule drug |
Synonyms IGP-002 |
Target |
Action inhibitors |
Mechanism JNK inhibitors(c-Jun N-terminal kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | United States | - | |
Parkinson Disease | Preclinical | United States | - |